Maytham T. Qasim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maytham T. Qasim has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Yasser Fakri Mustafa
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, Iraq
4 shared publications - Dmitry Olegovich Bokov
Institute of Pharmacy, Sechenov First Moscow State Medical University, 8 Trubetskaya St., bldg. 2, 119991 Moscow, Russia
3 shared publications Zainab I. Mohammed
Department of Basic Science, College of Dentistry, Al-Ayen Iraqi University, Thi-Qar, 64001, Iraq. Department of Physiology and Pharmacology, College of Veterinary Medicine, University of AL Qadisiyah, Iraq
3 shared publications- Abeer Abdullah Al Anazi
Department of Mechanical Engineering, Australian University (AU), Kuwait City 13015, Kuwait
2 shared publications - Filip Novak
Department of Electrical Power Engineering, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, 708-00 Ostrava, Czech Republic
2 shared publications - Hamzah H. Kzar
Department of Chemistry, College of Veterinary Medicine, Al-Qasim Green University, Al-Qasim, Iraq
2 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 14, 1952141
Correction: Application of novel Fe3O4/Zn-metal organic framework magnetic nanostructures as an antimicrobial agent and magnetic nanocatalyst in the synthesis of heterocyclic compounds
Correction on: Bashar S. Bashar, Hawraa A. Kareem, Yaser Mohamed Hasan, Nafis Ahmad, A. M. Alshehri, Kadhum Al-Majdi, Salema K. Hadrawi, Munthir Mohammed Radhy AL Kubaisy. And Maytham T. Qasim (2022) Application of novel Fe 3 O 4 /Zn-metal organic framework magnetic nanostructures as an antimicrobial agent and magnetic nanocatalyst in the synthesis of heterocyclic compounds. Front. Chem. 10:1014731. doi: 10.3389/fchem.2022.1014731. bashar.s.eng@nuc.edu.iq; alkareem@mustaqbal-college.edu.iq; yasir.mohammed0086@uoalfarahidi.edu.iq nafis.jmii@gmail.com; amshehrii@kku.edu.sa; dr.kadhum@au.edu.iq; sahadrawi@gmail.com; munthir.m.r@uom.edu.iq; dr.maytham@alayen.edu.iq;Adding/removing text In Section 2.1, General, the sentence: "Hitachi S-4800 FESEM (Field Emission Scanning Electron Microscope) for SEM image was used" incorrectly identified the SEM instrument. The SEM micrographs presented in Figure 6, panels I and III, and Figure 10, panel I, were acquired using a TESCAN MIRA3 field-emission scanning electron microscope (FE-SEM). For completeness and reproducibility, the acquisition conditions of the corrected SEM panels are clarified as follows. Figure 6(I), corresponding to the Fe3O4/Zn-MOF magnetic nanostructures, was acquired at an accelerating voltage of 15.0 kV, a working distance of 4.91 mm, using an InBeam detector, at a magnification of 200 k×, with a 200 nm scale bar. Figure 6(III), corresponding to the Fe3O4 nanoparticles, was acquired under the same conditions: an accelerating voltage of 15.0 kV, a working distance of 4.91 mm, using an InBeam detector, at a magnification of 200 k×, with a 200 nm scale bar. Figure 10(I), corresponding to the recovered Fe 3 O 4 /Zn-MOF magnetic nanostructures after catalytic reuse, was acquired at an accelerating voltage of 15.0 kV, a working distance of 4.91 mm, using an InBeam detector, at a magnification of 100 k×, with a 500 nm scale bar. Information regarding conductive coating was not documented in the retained experimental records and therefore cannot be specified reliably. The particle-size interpretation is also clarified. The average particle size of approximately 24 nm reported in the original article was determined from the SEM image and corresponding particle-size histogram presented in Figure 6(I-II) for the Fe 3 O 4 /Zn-MOF magnetic nanostructures. This value is in close agreement with the approximately 25 nm crystallite-size estimate obtained from the XRD analysis. The latter represents a crystallite-size estimate and should not be considered identical to the particle size determined from SEM. The original version of this article has been updated.
- 5 October 2026
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 14, 1952141
Open AccessCorrection: Application of novel Fe3O4/Zn-metal organic framework magnetic nanostructures as an antimicrobial agent and magnetic nanocatalyst in the synthesis of heterocyclic compounds
Correction on: Bashar S. Bashar, Hawraa A. Kareem, Yaser Mohamed Hasan, Nafis Ahmad, A. M. Alshehri, Kadhum Al-Majdi, Salema K. Hadrawi, Munthir Mohammed Radhy AL Kubaisy. And Maytham T. Qasim (2022) Application of novel Fe 3 O 4 /Zn-metal organic framework magnetic nanostructures as an antimicrobial agent and magnetic nanocatalyst in the synthesis of heterocyclic compounds. Front. Chem. 10:1014731. doi: 10.3389/fchem.2022.1014731. bashar.s.eng@nuc.edu.iq; alkareem@mustaqbal-college.edu.iq; yasir.mohammed0086@uoalfarahidi.edu.iq nafis.jmii@gmail.com; amshehrii@kku.edu.sa; dr.kadhum@au.edu.iq; sahadrawi@gmail.com; munthir.m.r@uom.edu.iq; dr.maytham@alayen.edu.iq;Adding/removing text In Section 2.1, General, the sentence: "Hitachi S-4800 FESEM (Field Emission Scanning Electron Microscope) for SEM image was used" incorrectly identified the SEM instrument. The SEM micrographs presented in Figure 6, panels I and III, and Figure 10, panel I, were acquired using a TESCAN MIRA3 field-emission scanning electron microscope (FE-SEM). For completeness and reproducibility, the acquisition conditions of the corrected SEM panels are clarified as follows. Figure 6(I), corresponding to the Fe3O4/Zn-MOF magnetic nanostructures, was acquired at an accelerating voltage of 15.0 kV, a working distance of 4.91 mm, using an InBeam detector, at a magnification of 200 k×, with a 200 nm scale bar. Figure 6(III), corresponding to the Fe3O4 nanoparticles, was acquired under the same conditions: an accelerating voltage of 15.0 kV, a working distance of 4.91 mm, using an InBeam detector, at a magnification of 200 k×, with a 200 nm scale bar. Figure 10(I), corresponding to the recovered Fe 3 O 4 /Zn-MOF magnetic nanostructures after catalytic reuse, was acquired at an accelerating voltage of 15.0 kV, a working distance of 4.91 mm, using an InBeam detector, at a magnification of 100 k×, with a 500 nm scale bar. Information regarding conductive coating was not documented in the retained experimental records and therefore cannot be specified reliably. The particle-size interpretation is also clarified. The average particle size of approximately 24 nm reported in the original article was determined from the SEM image and corresponding particle-size histogram presented in Figure 6(I-II) for the Fe 3 O 4 /Zn-MOF magnetic nanostructures. This value is in close agreement with the approximately 25 nm crystallite-size estimate obtained from the XRD analysis. The latter represents a crystallite-size estimate and should not be considered identical to the particle size determined from SEM. The original version of this article has been updated.
- Open Access
- 14 July 2025
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Biology
- Vol. 10 (3) , 633-637
The Therapeutic Potential of Curcuma longa (Turmeric) in the Management of Breast Cancer in Female Rats: Mechanisms and Molecular Targets
Background: Curcuma longa (turmeric), a traditional medicinal plant, has demonstrated significant antitumor properties in various cancer models. This study investigates the therapeutic efficacy of turmeric extract in the treatment of breast cancer in female rats, focusing on its mechanisms of action and molecular targets. Methods: Female Wistar rats were induced with mammary tumors using 7,12-dimethylbenz [a] anthracene (DMBA). The treated group received standardized doses of turmeric extract orally for six weeks. Tumor volume, histopathological changes, apoptosis markers (e.g., caspase-3), and oxidative stress biomarkers (e.g., MDA, SOD) were evaluated. Results: Rats treated with Curcuma longa showed a significant reduction in tumor size compared to the untreated group (p < 0.05). Histological analysis revealed increased apoptosis and reduced angiogenesis. Molecular assays indicated downregulation of NF-κB and upregulation of p53 expression. Conclusion: Turmeric demonstrated potent antitumor effects in breast cancer–induced rats through modulation of oxidative stress, inflammation, and apoptosis pathways. These findings support further investigation into Curcuma longa as a complementary therapeutic agent in breast cancer management.
- 14 July 2025
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Biology
- Vol. 10 (3) , 633-637
Open AccessThe Therapeutic Potential of Curcuma longa (Turmeric) in the Management of Breast Cancer in Female Rats: Mechanisms and Molecular Targets
Background: Curcuma longa (turmeric), a traditional medicinal plant, has demonstrated significant antitumor properties in various cancer models. This study investigates the therapeutic efficacy of turmeric extract in the treatment of breast cancer in female rats, focusing on its mechanisms of action and molecular targets. Methods: Female Wistar rats were induced with mammary tumors using 7,12-dimethylbenz [a] anthracene (DMBA). The treated group received standardized doses of turmeric extract orally for six weeks. Tumor volume, histopathological changes, apoptosis markers (e.g., caspase-3), and oxidative stress biomarkers (e.g., MDA, SOD) were evaluated. Results: Rats treated with Curcuma longa showed a significant reduction in tumor size compared to the untreated group (p < 0.05). Histological analysis revealed increased apoptosis and reduced angiogenesis. Molecular assays indicated downregulation of NF-κB and upregulation of p53 expression. Conclusion: Turmeric demonstrated potent antitumor effects in breast cancer–induced rats through modulation of oxidative stress, inflammation, and apoptosis pathways. These findings support further investigation into Curcuma longa as a complementary therapeutic agent in breast cancer management.
- Open Access
- 16 April 2025
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Biology
- Vol. 10 (2) , 261-268
Exploring the Immunological and Physiological Effects of Zingiber Officinale on Women with Ovarian Cancer in Iraq
Objective: Ovarian cancer is a major global health issue and ranks as the sixth most common cancer among women worldwide. Unfortunately, it is often diagnosed at an advanced stage, making treatment outcomes less favorable. This study examines the role of Zingiber officinale, commonly known as ginger, as a complementary therapy for women in Iraq battling ovarian cancer. It highlights ginger’s potential to improve the effectiveness of treatments and enhance patients’ quality of life. Methodology: The research used a mixed-methods approach, involving 57 participants over a 42-week period. It focused on the bioactive components of ginger such as gingerol, shogaol, paradol, and zingerone which are well-known for their anti-inflammatory, antioxidant, and immune-boosting properties. These compounds may work in tandem with traditional cancer treatments. Participants, categorized based on the stage of their cancer and their treatment regimens, were given ginger supplements alongside standard chemotherapy. The study carefully tracked and analyzed immune responses, physiological changes, and clinical outcomes. Results: The findings were notable. Ginger supplementation significantly boosted T-helper cell activity, improved CD4/CD8 ratios, and lowered inflammatory cytokine levels. Physiologically, participants experienced better antioxidant activity, reduced chemotherapy-induced nausea, and better fatigue management. Perhaps most strikingly, those taking ginger required fewer secondary surgeries and additional chemotherapy sessions. Their biochemical markers, including CA-125 levels, lipid profiles, and oxidative stress markers, also showed improvement. The research highlights ginger’s potential as a valuable addition to traditional cancer treatments, helping to strengthen the immune system and body while reducing the side effects of therapy. However, the study did face some limitations, such as a relatively small sample size, a lack of diverse participants, and limited resources. Further research is needed to confirm these findings. Future studies should involve larger and more diverse groups of participants, extend the duration of observation, and explore ginger’s effects on other types of cancer to broaden the scope of its benefits. Conclusion: Ultimately, this study advocates for incorporating ginger into cancer care protocols due to its affordability, accessibility, and minimal side effects. By integrating ginger into oncology practices, healthcare providers can potentially revolutionize supportive care for ovarian cancer patients, paving the way for holistic well-being and better treatment outcomes.
- 16 April 2025
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Biology
- Vol. 10 (2) , 261-268
Open AccessExploring the Immunological and Physiological Effects of Zingiber Officinale on Women with Ovarian Cancer in Iraq
Objective: Ovarian cancer is a major global health issue and ranks as the sixth most common cancer among women worldwide. Unfortunately, it is often diagnosed at an advanced stage, making treatment outcomes less favorable. This study examines the role of Zingiber officinale, commonly known as ginger, as a complementary therapy for women in Iraq battling ovarian cancer. It highlights ginger’s potential to improve the effectiveness of treatments and enhance patients’ quality of life. Methodology: The research used a mixed-methods approach, involving 57 participants over a 42-week period. It focused on the bioactive components of ginger such as gingerol, shogaol, paradol, and zingerone which are well-known for their anti-inflammatory, antioxidant, and immune-boosting properties. These compounds may work in tandem with traditional cancer treatments. Participants, categorized based on the stage of their cancer and their treatment regimens, were given ginger supplements alongside standard chemotherapy. The study carefully tracked and analyzed immune responses, physiological changes, and clinical outcomes. Results: The findings were notable. Ginger supplementation significantly boosted T-helper cell activity, improved CD4/CD8 ratios, and lowered inflammatory cytokine levels. Physiologically, participants experienced better antioxidant activity, reduced chemotherapy-induced nausea, and better fatigue management. Perhaps most strikingly, those taking ginger required fewer secondary surgeries and additional chemotherapy sessions. Their biochemical markers, including CA-125 levels, lipid profiles, and oxidative stress markers, also showed improvement. The research highlights ginger’s potential as a valuable addition to traditional cancer treatments, helping to strengthen the immune system and body while reducing the side effects of therapy. However, the study did face some limitations, such as a relatively small sample size, a lack of diverse participants, and limited resources. Further research is needed to confirm these findings. Future studies should involve larger and more diverse groups of participants, extend the duration of observation, and explore ginger’s effects on other types of cancer to broaden the scope of its benefits. Conclusion: Ultimately, this study advocates for incorporating ginger into cancer care protocols due to its affordability, accessibility, and minimal side effects. By integrating ginger into oncology practices, healthcare providers can potentially revolutionize supportive care for ovarian cancer patients, paving the way for holistic well-being and better treatment outcomes.
- Open Access
- 5 October 2024
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Biology
- Vol. 9 (4) , 541-545
The Association of Helicobacter pylori Infection and Virulence Factors in Gastric Cancer in Thi-Qar, Iraq
Background: The significance of Helicobacter pylori (H. pylori) infection in developing gastric cancer has been increasingly recognized. However, a noticeable gap exists in the literature regarding the prevalence of key virulence factors, particularly in Iraq. Therefore, Our study aimed to investigate the prevalence of H. pylori infection and the presence of virulence factors, namely the CagA and VacA genes, in gastric cancer patients. Methods: A case-control study was conducted on 45 gastric cancer patients (38 males and 7 females) from September 2020 to February 2021. During routine endoscopic procedures, gastric biopsy specimens were collected from the tumour and adjacent non-tumour tissues. The presence of H. pylori was detected using quantitative real-time PCR, and the virulence factors CagA and vacA were identified using specific primers. Results: H. pylori infection was detected in a significant 85% (38/45) of the patients, with a higher prevalence in males 89.5% (34/38) compared to females 10.5% (4/38) (P=0.021) (Chi-square test). No significant age-related differences were observed. The CagA gene was present in a substantial 58.8% (22/38) of H. pylori-positive patients, predominantly in tumor tissues at 81.81% (18/22), while the vacA gene was found in only one patient. These results underscore the importance of our research in understanding the prevalence of H. pylori infection and the presence of virulence factors in gastric cancer patients. Conclusion: The high prevalence of H. pylori infection and the significant presence of the CagA virulence factor in tumour tissues underscore the bacterium’s role and risk factors in gastric carcinogenesis in Thi-Qar, Iraq.
- 5 October 2024
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Biology
- Vol. 9 (4) , 541-545
Open AccessThe Association of Helicobacter pylori Infection and Virulence Factors in Gastric Cancer in Thi-Qar, Iraq
Background: The significance of Helicobacter pylori (H. pylori) infection in developing gastric cancer has been increasingly recognized. However, a noticeable gap exists in the literature regarding the prevalence of key virulence factors, particularly in Iraq. Therefore, Our study aimed to investigate the prevalence of H. pylori infection and the presence of virulence factors, namely the CagA and VacA genes, in gastric cancer patients. Methods: A case-control study was conducted on 45 gastric cancer patients (38 males and 7 females) from September 2020 to February 2021. During routine endoscopic procedures, gastric biopsy specimens were collected from the tumour and adjacent non-tumour tissues. The presence of H. pylori was detected using quantitative real-time PCR, and the virulence factors CagA and vacA were identified using specific primers. Results: H. pylori infection was detected in a significant 85% (38/45) of the patients, with a higher prevalence in males 89.5% (34/38) compared to females 10.5% (4/38) (P=0.021) (Chi-square test). No significant age-related differences were observed. The CagA gene was present in a substantial 58.8% (22/38) of H. pylori-positive patients, predominantly in tumor tissues at 81.81% (18/22), while the vacA gene was found in only one patient. These results underscore the importance of our research in understanding the prevalence of H. pylori infection and the presence of virulence factors in gastric cancer patients. Conclusion: The high prevalence of H. pylori infection and the significant presence of the CagA virulence factor in tumour tissues underscore the bacterium’s role and risk factors in gastric carcinogenesis in Thi-Qar, Iraq.
- 24 September 2024
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 80 (4) , 811-829
MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells
Exosomes are widely recognized for their roles in numerous biological processes and as intercellular communication mediators. Human cancerous and normal cells can both produce massive amounts of exosomes. They are extensively dispersed in tumor-modeling animals’ pleural effusions, ascites, and plasma from people with cancer. Tumor cells interact with host cells by releasing exosomes, which allow them to interchange various biological components. Tumor growth, invasion, metastasis, and even tumorigenesis can all be facilitated by this delicate and complex system by modifying the nearby and remote surroundings. Due to the existence of significant levels of biomolecules like microRNA, exosomes can modulate the immune system’s stimulation or repression, which in turn controls tumor growth. However, the role of microRNA in exosome-mediated communication between immunological and cancer cells is still poorly understood. This study aims to get the most recent information on the “yin and yang” of exosomal microRNA in the regulation of tumor immunity and immunotherapy, which will aid current cancer treatment and diagnostic techniques.
- 24 September 2024
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 80 (4) , 811-829
MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells
Exosomes are widely recognized for their roles in numerous biological processes and as intercellular communication mediators. Human cancerous and normal cells can both produce massive amounts of exosomes. They are extensively dispersed in tumor-modeling animals’ pleural effusions, ascites, and plasma from people with cancer. Tumor cells interact with host cells by releasing exosomes, which allow them to interchange various biological components. Tumor growth, invasion, metastasis, and even tumorigenesis can all be facilitated by this delicate and complex system by modifying the nearby and remote surroundings. Due to the existence of significant levels of biomolecules like microRNA, exosomes can modulate the immune system’s stimulation or repression, which in turn controls tumor growth. However, the role of microRNA in exosome-mediated communication between immunological and cancer cells is still poorly understood. This study aims to get the most recent information on the “yin and yang” of exosomal microRNA in the regulation of tumor immunity and immunotherapy, which will aid current cancer treatment and diagnostic techniques.
- RetractionOpen Access
RETRACTED: Anazi et al. Investigation and Evaluation of the Hybrid System of Energy Storage for Renewable Energies. Energies 2023, 16, 2337
The journal Energies retracts the article “Investigation and Evaluation of the Hybrid System of Energy Storage for Renewable Energies”
RetractionOpen AccessRETRACTED: Anazi et al. Investigation and Evaluation of the Hybrid System of Energy Storage for Renewable Energies. Energies 2023, 16, 2337
The journal Energies retracts the article “Investigation and Evaluation of the Hybrid System of Energy Storage for Renewable Energies”
- 17 May 2024
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 50 (7) , 3109-3133
Nano-SiO2@nPr@DPyE-Ni: a novel nanocatalyst for the rapid production of symmetric di-aryl sulfides and pyrazolones
- 17 May 2024
- Published by Springer Nature in Research on Chemical Intermediates
- Vol. 50 (7) , 3109-3133
Nano-SiO2@nPr@DPyE-Ni: a novel nanocatalyst for the rapid production of symmetric di-aryl sulfides and pyrazolones
- RetractedOpen Access
RETRACTED: Investigation and Evaluation of the Hybrid System of Energy Storage for Renewable Energies
The system presented in this paper can change the energy storage landscape by having the advantages of a compressed air storage system and pump storage, as well as minimizing the disadvantages of these two systems. One of the advantages of this system compared to similar systems is the lack of combustion of natural gas. Correspondingly, for construction, it does not require specific specifications for the executive site, and control of the energy and heat of the system (due to the use of water as an operational fluid) is easier than similar systems. In addition, this system is very scalable and can be designed in low capacities to high capacities, energy analysis of this research to identify the basic and effective parameters of the system and determine the limitations and relationships between them. The amount of energy saved in the current research system compared to previous research is significant, and 92% efficiency can be achieved. The energy analysis of this research determined the effect of the parameters on each other and their limitations so that the path of its feasibility design was paved.
RetractedOpen AccessRETRACTED: Investigation and Evaluation of the Hybrid System of Energy Storage for Renewable Energies
The system presented in this paper can change the energy storage landscape by having the advantages of a compressed air storage system and pump storage, as well as minimizing the disadvantages of these two systems. One of the advantages of this system compared to similar systems is the lack of combustion of natural gas. Correspondingly, for construction, it does not require specific specifications for the executive site, and control of the energy and heat of the system (due to the use of water as an operational fluid) is easier than similar systems. In addition, this system is very scalable and can be designed in low capacities to high capacities, energy analysis of this research to identify the basic and effective parameters of the system and determine the limitations and relationships between them. The amount of energy saved in the current research system compared to previous research is significant, and 92% efficiency can be achieved. The energy analysis of this research determined the effect of the parameters on each other and their limitations so that the path of its feasibility design was paved.
- 21 March 2022
- Published by Springer Nature in Rendiconti Lincei. Scienze Fisiche e Naturali
- Vol. 33 (2) , 441-447
Cytotoxicity evaluation of environmentally friendly synthesis Copper/Zinc bimetallic nanoparticles on MCF-7 cancer cells
Bimetallic nanoparticles offer unique chemical, physical and optical properties that are not available for monometallic nanoparticles. Bimetallic nanoparticles play a major role in various therapeutic, industrial and energy fields. Recently, nanoparticles of Copper/Zinc bimetallic nanoparticles have attracted attention in various fields, especially medicine. In this study, bimetallic CuO/ZnO nanostructures were biosynthesized using plant extracts. The plant-mediated synthesis nanoparticles were characterized by Transmission electron microscopy (TEM), X-ray diffraction analysis (XRD), Field Emission Scanning Electron Microscopy (FESEM) and Energy-Dispersive Spectroscopy (EDAX). The cytotoxicity of plant-mediated synthesis bimetallic nanoparticles and the synergistic effects of these nanoparticles in combination with the anticancer drug doxorubicin on MCF-7 cancer cells were evaluated by MTT assay.
- 21 March 2022
- Published by Springer Nature in Rendiconti Lincei. Scienze Fisiche e Naturali
- Vol. 33 (2) , 441-447
Cytotoxicity evaluation of environmentally friendly synthesis Copper/Zinc bimetallic nanoparticles on MCF-7 cancer cells
Bimetallic nanoparticles offer unique chemical, physical and optical properties that are not available for monometallic nanoparticles. Bimetallic nanoparticles play a major role in various therapeutic, industrial and energy fields. Recently, nanoparticles of Copper/Zinc bimetallic nanoparticles have attracted attention in various fields, especially medicine. In this study, bimetallic CuO/ZnO nanostructures were biosynthesized using plant extracts. The plant-mediated synthesis nanoparticles were characterized by Transmission electron microscopy (TEM), X-ray diffraction analysis (XRD), Field Emission Scanning Electron Microscopy (FESEM) and Energy-Dispersive Spectroscopy (EDAX). The cytotoxicity of plant-mediated synthesis bimetallic nanoparticles and the synergistic effects of these nanoparticles in combination with the anticancer drug doxorubicin on MCF-7 cancer cells were evaluated by MTT assay.